NELSON MULLINS RILEY & SCARBOROUGH

Lobbying for ANBEX, INC. · Pharmaceutical Manufacturing

Filing 4th Quarter - Report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 9, 2026

Income

$15,000.00

What the client paid this registrant for the period.

Client based in

Maryland

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 2

Medical/Disease Research/Clinical Labs

Stockpile potassium iodide to counteract effects of nuclear radiation.

Energy/Nuclear

The utilization of potassium iodide to protect against nuclear radiation.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.